Days At A Glance Speakers Session Type Search
Type

    13:15 - 14:15 
    Novo Nordisk Sponsored Satellite Symposium
    Growth Hormone Replacement with Once-Weekly Somapacitan in Children with GHD
    Atlantic
    Thu 21
    Novo Nordisk Sponsored Satellite Symposium
    Opening remarks
    Stockholm, Sweden
    Thu 21
    Novo Nordisk Sponsored Satellite Symposium
    A Critical Review of Somapacitan Data in GHD
    Minneapolis, USA
    Thu 21
    Novo Nordisk Sponsored Satellite Symposium
    First Clinical Experience in Managing Children with GHD Treated with Somapacitan
    Saudi Arabia
    Thu 21
    Novo Nordisk Sponsored Satellite Symposium
    Q&A
    Thu 21
    Novo Nordisk Sponsored Satellite Symposium
    Closing remarks
    Stockholm, Sweden
    17:50 - 19:20 
    Kyowa Kirin Sponsored Satellite Symposium
    Who, What and When: Multidisciplinary Team Management of Rare Bone Diseases
    This event is intended for healthcare professionals only who are registered for ESPE 2023. This promotional symposium is organised and funded by Kyowa Kirin and will contain data about Kyowa Kirin products. August 2023 | KKI/INT/CYS/0162 | KKI/NL/CYS/0355
    Amazon
    Thu 21 17:50
    Kyowa Kirin Sponsored Satellite Symposium
    Welcome and introductions
    The Netherlands
    Thu 21 17:55
    Kyowa Kirin Sponsored Satellite Symposium
    Optimising multidisciplinary team management in rare bone diseases
    UK
    Thu 21 18:10
    Kyowa Kirin Sponsored Satellite Symposium
    A collaborative approach to managing patients with rare bone diseases: Interactive case studies discussing XLH, OI and others
    Thu 21 19:10
    Kyowa Kirin Sponsored Satellite Symposium
    Summary, Final Questions and Close
    The Netherlands
    17:50 - 19:20 
    Sandoz Satellite Sponsored Symposium
    Delayed puberty: Navigating the clinical landscape
    Atlantic
    Thu 21 17:50
    Sandoz Satellite Sponsored Symposium
    Welcome and introduction
    Copenhagen, Denmark
    Thu 21 17:55
    Sandoz Satellite Sponsored Symposium
    Natural course and genetic etiologies
    Lausanne, Switzerland
    Thu 21 18:15
    Sandoz Satellite Sponsored Symposium
    Q&A
    Thu 21 18:20
    Sandoz Satellite Sponsored Symposium
    Diagnosis of delayed puberty versus congenital hypogonadotropic hypogonadism
    London, UK
    Thu 21 18:40
    Sandoz Satellite Sponsored Symposium
    Q&A
    Thu 21 18:45
    Sandoz Satellite Sponsored Symposium
    Old and emerging therapies
    Helsinki, Finland
    Thu 21 19:05
    Sandoz Satellite Sponsored Symposium
    Q&A session
    Thu 21 19:10
    Sandoz Satellite Sponsored Symposium
    Panel discussion and meeting close
    13:15 - 14:15 
    Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
    Hyperphagia and early-onset, severe obesity: The role of precision medicine in the treatment of leptin melanocortin-4 receptor (MC4R) pathway diseases
    Amazon
    Thu 21 13:15
    Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
    Welcome and introductions
    Rotterdam, The Netherlands
    Thu 21 13:18
    Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
    Genetic impairments in the MC4R pathway and their role in hyperphagia and early-onset, severe obesity
    The Netherlands
    Thu 21 13:28
    Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
    Overview of MC4R pathway diseases, including Bardet-Biedl syndrome (BBS)
    UK
    Thu 21 13:38
    Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
    The role of precision medicine in the management of BBS and other MC4R pathway diseases
    The Netherlands
    Thu 21 13:48
    Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
    Group discussion: Diagnosis and genetic testing
    Thu 21 14:13
    Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
    Summary and close
    Rotterdam, The Netherlands
    17:50 - 19:20 
    Ascendis Sponsored Satellite Symposium
    The future is Long-Acting Growth Hormones
    Pacific
    Thu 21 17:50
    Ascendis Sponsored Satellite Symposium
    SKYTROFA® (lonapegsomatropin): Rationale and Design
    Palo Alto, USA
    Thu 21 18:05
    Ascendis Sponsored Satellite Symposium
    LAGH Formulations: Are they all the same?
    Thu 21 18:30
    Ascendis Sponsored Satellite Symposium
    Clinical Data and Experience with lonapegsomatropin
    USA
    Thu 21 19:10
    Ascendis Sponsored Satellite Symposium
    Panel Discussion

    13:20 - 14:20 
    Pfizer Sponsored Satellite Symposium
    Addressing patient needs in paediatric growth hormone deficiency
    Atlantic
    Chair: Lars Savendahl (Stockholm, Sweden)
    Fri 22
    Pfizer Sponsored Satellite Symposium
    Welcome, introduction, and objectives
    Stockholm, Sweden
    Fri 22
    Pfizer Sponsored Satellite Symposium
    Patient and caregiver perspectives in pGHD
    Icosep, USA
    Fri 22
    Pfizer Sponsored Satellite Symposium
    The evidence to date: Long term data from the Somatrogon Clinical Trial Program
    Oregon, USA
    Fri 22
    Pfizer Sponsored Satellite Symposium
    Somatrogon in practice: Patient Case Studies
    Liverpool, UK
    Fri 22
    Pfizer Sponsored Satellite Symposium
    Panel Discussion
    13:20 - 14:20 
    Merck Sponsored Satellite Symposium
    Integrated care using evidence based digital health solutions – are we ready for guidelines?
    Pacific
    Chair: Jan-Maarten M Wit (Leiden, The Netherlands)
    Fri 22
    Merck Sponsored Satellite Symposium
    Leveraging knowledge from diabetes ecosystem for innovation in digital health technologies
    Petah Tikva, Israel
    Fri 22
    Merck Sponsored Satellite Symposium
    User centered approach in assessment of connected autoinjectors for patients requiring GH therapy
    Zaragoza, Spain
    Fri 22
    Merck Sponsored Satellite Symposium
    Current perspectives on evidence based therapeutic interventions from real world data in growth hormone therapy
    Cagliari, Italy
    Fri 22
    Merck Sponsored Satellite Symposium
    Panel Discussion
    17:00 - 18:30 
    BioMarin Sponsored Satellite Symposium
    Advancing the standard of care for achondroplasia: Integrating clinical and real-world evidence to improve treatment strategies
    Mississippi
    Fri 22
    BioMarin Sponsored Satellite Symposium
    Introduction and objectives
    London, UK
    Fri 22
    BioMarin Sponsored Satellite Symposium
    Growing up with vosoritide▼: Long-term efficacy in children of different ages.
    Istanbul, Turkey
    London, UK
    Fri 22
    BioMarin Sponsored Satellite Symposium
    From trials to treatment: Real-world experience with vosoritide
    Paris, France
    London, UK
    Homburg, Germany
    Istanbul, Turkey
    Fri 22
    BioMarin Sponsored Satellite Symposium
    Q&A and closing remarks
    London, UK
    Fri 22
    BioMarin Sponsored Satellite Symposium
    ▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. Healthcare professionals should report adverse events in accordance with their local requirements. Adverse events should also be reported to BioMarin on + 1 415 506 6179 or [email protected].
    17:00 - 18:30 
    Amryt Pharma Sponsored Satellite Symposium
    The holistic approach to the child with lipodystrophy: The importance of timely diagnosis, intervention and education
    Amazon
    Chair: Ingrid Jazet (The Netherlands)
    Fri 22 17:00
    Amryt Pharma Sponsored Satellite Symposium
    Introduction and the complex pathophysiology of leptin deficiency
    The Netherlands
    Fri 22 17:10
    Amryt Pharma Sponsored Satellite Symposium
    The early onset burden of lipodystrophy: lessons from the paediatric population
    University of Ulm, Germany
    Fri 22 17:35
    Amryt Pharma Sponsored Satellite Symposium
    Treatment approaches to the child with lipodystrophy
    Cambridge, UK
    Fri 22 18:00
    Amryt Pharma Sponsored Satellite Symposium
    Patient education initiatives in lipodystrophy: learnings from the LIPEA program
    France
    Fri 22 18:20
    Amryt Pharma Sponsored Satellite Symposium
    Conclusions and Q&A
    08:15 - 08:45 
    Industry Expert Forum (Novo Nordisk)
    Auxological and cardiovascular outcomes of long-term GH therapy in children with Noonan syndrome
    Oceania
    Fri 22 08:15
    Industry Expert Forum (Novo Nordisk)
    Auxological and cardiovascular outcomes of long-term GH therapy in children with Noonan syndrome
    Japan
    09:00 - 09:30 
    Industry Expert Forum (Neurocrine Biosciences and Diurnal)
    Overcoming obstacles on the way to a precise, effective and well-tolerated therapy for Adrenal Insufficiency and Congenital Adrenal Hyperplasia in childhood and adolescence
    Oceania
    Fri 22 09:00
    Industry Expert Forum (Neurocrine Biosciences and Diurnal)
    Welcome and Introductions
    Fri 22 09:05
    Industry Expert Forum (Neurocrine Biosciences and Diurnal)
    Overcoming obstacles on the way to a precise, effective and well-tolerated therapy for Adrenal Insufficiency and Congenital Adrenal Hyperplasia in childhood and adolescence
    Fri 22 09:25
    Industry Expert Forum (Neurocrine Biosciences and Diurnal)
    Questions and Answers
    Fri 22 09:30
    Industry Expert Forum (Neurocrine Biosciences and Diurnal)
    Symposium Close
    09:00 - 09:30 
    Industry Expert Forum (Pfizer)
    How to measure for Quality of Life for pGHD in the clinic
    Everest 1&2
    Chair: Gary Butler (UK)
    Fri 22 09:00
    Industry Expert Forum (Pfizer)
    Leverage unmet need, disease & treatment burden
Lars	Sävendahl
Stockholm, Sweden
Thu 21
Novo Nordisk Sponsored Satellite Symposium
Opening remarks
Stockholm, Sweden
Thu 21
Novo Nordisk Sponsored Satellite Symposium
Closing remarks
Stockholm, Sweden
All faculty
Thu 21
Novo Nordisk Sponsored Satellite Symposium
Q&A
Lars	Sävendahl
Stockholm, Sweden
Thu 21
Novo Nordisk Sponsored Satellite Symposium
Opening remarks
Stockholm, Sweden
Thu 21
Novo Nordisk Sponsored Satellite Symposium
Closing remarks
Stockholm, Sweden
Moshe	Phillip
Petah Tikva, Israel
Fri 22
Merck Sponsored Satellite Symposium
Leveraging knowledge from diabetes ecosystem for innovation in digital health technologies
Petah Tikva, Israel
Moira Cheung
London, UK
Fri 22
BioMarin Sponsored Satellite Symposium
Introduction and objectives
London, UK
Fri 22
BioMarin Sponsored Satellite Symposium
From trials to treatment: Real-world experience with vosoritide
Paris, France
London, UK
Homburg, Germany
Istanbul, Turkey
Fri 22
BioMarin Sponsored Satellite Symposium
Q&A and closing remarks
London, UK
Yasemin Alanay
Istanbul, Turkey
Fri 22
BioMarin Sponsored Satellite Symposium
Growing up with vosoritide▼: Long-term efficacy in children of different ages.
Istanbul, Turkey
London, UK
Fri 22
BioMarin Sponsored Satellite Symposium
From trials to treatment: Real-world experience with vosoritide
Paris, France
London, UK
Homburg, Germany
Istanbul, Turkey
Genevieve Baujat
Paris, France
Fri 22
BioMarin Sponsored Satellite Symposium
From trials to treatment: Real-world experience with vosoritide
Paris, France
London, UK
Homburg, Germany
Istanbul, Turkey
Annemieke Boot
The Netherlands
Thu 21 17:50
Kyowa Kirin Sponsored Satellite Symposium
Welcome and introductions
The Netherlands
Thu 21 19:10
Kyowa Kirin Sponsored Satellite Symposium
Summary, Final Questions and Close
The Netherlands
Christine Burren
UK
Thu 21 17:55
Kyowa Kirin Sponsored Satellite Symposium
Optimising multidisciplinary team management in rare bone diseases
UK
Antonio de Arriba
Zaragoza, Spain
Fri 22
Merck Sponsored Satellite Symposium
User centered approach in assessment of connected autoinjectors for patients requiring GH therapy
Zaragoza, Spain
Dr Corjan de Groot
The Netherlands
Thu 21 13:38
Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
The role of precision medicine in the management of BBS and other MC4R pathway diseases
The Netherlands
Waljit Dhillo
London, UK
Thu 21 18:20
Sandoz Satellite Sponsored Symposium
Diagnosis of delayed puberty versus congenital hypogonadotropic hypogonadism
London, UK
Abdulmoein Eid Al-Agha
Saudi Arabia
Thu 21
Novo Nordisk Sponsored Satellite Symposium
First Clinical Experience in Managing Children with GHD Treated with Somapacitan
Saudi Arabia
Elizabeth Forsythe
UK
Thu 21 13:28
Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
Overview of MC4R pathway diseases, including Bardet-Biedl syndrome (BBS)
UK
Jamie  Harvey
Icosep, USA
Fri 22
Pfizer Sponsored Satellite Symposium
Patient and caregiver perspectives in pGHD
Icosep, USA
Dr Reiko Horikawa
Japan
Fri 22 08:15
Industry Expert Forum (Novo Nordisk)
Auxological and cardiovascular outcomes of long-term GH therapy in children with Noonan syndrome
Japan
Melita Irving
London, UK
Fri 22
BioMarin Sponsored Satellite Symposium
Growing up with vosoritide▼: Long-term efficacy in children of different ages.
Istanbul, Turkey
London, UK
Ingrid  Jazet
The Netherlands
Fri 22 17:00
Amryt Pharma Sponsored Satellite Symposium
Introduction and the complex pathophysiology of leptin deficiency
The Netherlands
Anders Juul
Copenhagen, Denmark
Thu 21 17:50
Sandoz Satellite Sponsored Symposium
Welcome and introduction
Copenhagen, Denmark
Sandro Loche
Cagliari, Italy
Fri 22
Merck Sponsored Satellite Symposium
Current perspectives on evidence based therapeutic interventions from real world data in growth hormone therapy
Cagliari, Italy
Aristides Maniatis
USA
Thu 21 18:30
Ascendis Sponsored Satellite Symposium
Clinical Data and Experience with lonapegsomatropin
USA
Bradley Miller
Minneapolis, USA
Thu 21
Novo Nordisk Sponsored Satellite Symposium
A Critical Review of Somapacitan Data in GHD
Minneapolis, USA
Nelly Pitteloud
Lausanne, Switzerland
Thu 21 17:55
Sandoz Satellite Sponsored Symposium
Natural course and genetic etiologies
Lausanne, Switzerland
Tilman Rohrer
Homburg, Germany
Fri 22
BioMarin Sponsored Satellite Symposium
From trials to treatment: Real-world experience with vosoritide
Paris, France
London, UK
Homburg, Germany
Istanbul, Turkey
Ron Rosenfeld
Oregon, USA
Fri 22
Pfizer Sponsored Satellite Symposium
The evidence to date: Long term data from the Somatrogon Clinical Trial Program
Oregon, USA
Lars Sävendal
Stockholm, Sweden
Fri 22
Pfizer Sponsored Satellite Symposium
Welcome, introduction, and objectives
Stockholm, Sweden
Senthil Senniappan
Liverpool, UK
Fri 22
Pfizer Sponsored Satellite Symposium
Somatrogon in practice: Patient Case Studies
Liverpool, UK
Kennett Sprogøe
Palo Alto, USA
Thu 21 17:50
Ascendis Sponsored Satellite Symposium
SKYTROFA® (lonapegsomatropin): Rationale and Design
Palo Alto, USA
Erica van den Akker
Rotterdam, The Netherlands
Thu 21 13:15
Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
Welcome and introductions
Rotterdam, The Netherlands
Thu 21 14:13
Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
Summary and close
Rotterdam, The Netherlands
Prof Mieke van Haelst
The Netherlands
Thu 21 13:18
Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
Genetic impairments in the MC4R pathway and their role in hyperphagia and early-onset, severe obesity
The Netherlands
Tero Varimo
Helsinki, Finland
Thu 21 18:45
Sandoz Satellite Sponsored Symposium
Old and emerging therapies
Helsinki, Finland
Camille  Vatier
France
Fri 22 18:00
Amryt Pharma Sponsored Satellite Symposium
Patient education initiatives in lipodystrophy: learnings from the LIPEA program
France
Professor Martin Wabitsch
University of Ulm, Germany
Fri 22 17:10
Amryt Pharma Sponsored Satellite Symposium
The early onset burden of lipodystrophy: lessons from the paediatric population
University of Ulm, Germany
Rachel Williams
Cambridge, UK
Fri 22 17:35
Amryt Pharma Sponsored Satellite Symposium
Treatment approaches to the child with lipodystrophy
Cambridge, UK
Kevin Yuen
Thu 21 18:05
Ascendis Sponsored Satellite Symposium
LAGH Formulations: Are they all the same?
Workshop 0
Oral 0
Expert 0
Plenary 0
Catering and Social 0
Nurse 0
Other 0
Symposium 8
Thu 21 13:15
Novo Nordisk Sponsored Satellite Symposium
Growth Hormone Replacement with Once-Weekly Somapacitan in Children with GHD
Atlantic
Thu 21
Novo Nordisk Sponsored Satellite Symposium
Opening remarks
Stockholm, Sweden
Thu 21
Novo Nordisk Sponsored Satellite Symposium
A Critical Review of Somapacitan Data in GHD
Minneapolis, USA
Thu 21
Novo Nordisk Sponsored Satellite Symposium
First Clinical Experience in Managing Children with GHD Treated with Somapacitan
Saudi Arabia
Thu 21
Novo Nordisk Sponsored Satellite Symposium
Q&A
Thu 21
Novo Nordisk Sponsored Satellite Symposium
Closing remarks
Stockholm, Sweden
Thu 21 17:50
Kyowa Kirin Sponsored Satellite Symposium
Who, What and When: Multidisciplinary Team Management of Rare Bone Diseases
This event is intended for healthcare professionals only who are registered for ESPE 2023. This promotional symposium is organised and funded by Kyowa Kirin and will contain data about Kyowa Kirin products. August 2023 | KKI/INT/CYS/0162 | KKI/NL/CYS/0355
Amazon
Thu 21 17:50
Kyowa Kirin Sponsored Satellite Symposium
Welcome and introductions
The Netherlands
Thu 21 17:55
Kyowa Kirin Sponsored Satellite Symposium
Optimising multidisciplinary team management in rare bone diseases
UK
Thu 21 18:10
Kyowa Kirin Sponsored Satellite Symposium
A collaborative approach to managing patients with rare bone diseases: Interactive case studies discussing XLH, OI and others
Thu 21 19:10
Kyowa Kirin Sponsored Satellite Symposium
Summary, Final Questions and Close
The Netherlands
Thu 21 17:50
Sandoz Satellite Sponsored Symposium
Delayed puberty: Navigating the clinical landscape
Atlantic
Thu 21 17:50
Sandoz Satellite Sponsored Symposium
Welcome and introduction
Copenhagen, Denmark
Thu 21 17:55
Sandoz Satellite Sponsored Symposium
Natural course and genetic etiologies
Lausanne, Switzerland
Thu 21 18:15
Sandoz Satellite Sponsored Symposium
Q&A
Thu 21 18:20
Sandoz Satellite Sponsored Symposium
Diagnosis of delayed puberty versus congenital hypogonadotropic hypogonadism
London, UK
Thu 21 18:40
Sandoz Satellite Sponsored Symposium
Q&A
Thu 21 18:45
Sandoz Satellite Sponsored Symposium
Old and emerging therapies
Helsinki, Finland
Thu 21 19:05
Sandoz Satellite Sponsored Symposium
Q&A session
Thu 21 19:10
Sandoz Satellite Sponsored Symposium
Panel discussion and meeting close
Thu 21 13:15
Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
Hyperphagia and early-onset, severe obesity: The role of precision medicine in the treatment of leptin melanocortin-4 receptor (MC4R) pathway diseases
Amazon
Thu 21 13:15
Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
Welcome and introductions
Rotterdam, The Netherlands
Thu 21 13:18
Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
Genetic impairments in the MC4R pathway and their role in hyperphagia and early-onset, severe obesity
The Netherlands
Thu 21 13:28
Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
Overview of MC4R pathway diseases, including Bardet-Biedl syndrome (BBS)
UK
Thu 21 13:38
Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
The role of precision medicine in the management of BBS and other MC4R pathway diseases
The Netherlands
Thu 21 13:48
Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
Group discussion: Diagnosis and genetic testing
Thu 21 14:13
Rhythm Pharmaceuticals Sponsored Promotional Satellite Symposium
Summary and close
Rotterdam, The Netherlands
Fri 22 13:20
Pfizer Sponsored Satellite Symposium
Addressing patient needs in paediatric growth hormone deficiency
Atlantic
Chair: Lars Savendahl (Stockholm, Sweden)
Fri 22
Pfizer Sponsored Satellite Symposium
Welcome, introduction, and objectives
Stockholm, Sweden
Fri 22
Pfizer Sponsored Satellite Symposium
Patient and caregiver perspectives in pGHD
Icosep, USA
Fri 22
Pfizer Sponsored Satellite Symposium
The evidence to date: Long term data from the Somatrogon Clinical Trial Program
Oregon, USA
Fri 22
Pfizer Sponsored Satellite Symposium
Somatrogon in practice: Patient Case Studies
Liverpool, UK
Fri 22
Pfizer Sponsored Satellite Symposium
Panel Discussion
Fri 22 13:20
Merck Sponsored Satellite Symposium
Integrated care using evidence based digital health solutions – are we ready for guidelines?
Pacific
Chair: Jan-Maarten M Wit (Leiden, The Netherlands)
Fri 22
Merck Sponsored Satellite Symposium
Leveraging knowledge from diabetes ecosystem for innovation in digital health technologies
Petah Tikva, Israel
Fri 22
Merck Sponsored Satellite Symposium
User centered approach in assessment of connected autoinjectors for patients requiring GH therapy
Zaragoza, Spain
Fri 22
Merck Sponsored Satellite Symposium
Current perspectives on evidence based therapeutic interventions from real world data in growth hormone therapy
Cagliari, Italy
Fri 22
Merck Sponsored Satellite Symposium
Panel Discussion
Fri 22 17:00
BioMarin Sponsored Satellite Symposium
Advancing the standard of care for achondroplasia: Integrating clinical and real-world evidence to improve treatment strategies
Mississippi
Fri 22
BioMarin Sponsored Satellite Symposium
Introduction and objectives
London, UK
Fri 22
BioMarin Sponsored Satellite Symposium
Growing up with vosoritide▼: Long-term efficacy in children of different ages.
Istanbul, Turkey
London, UK
Fri 22
BioMarin Sponsored Satellite Symposium
From trials to treatment: Real-world experience with vosoritide
Paris, France
London, UK
Homburg, Germany
Istanbul, Turkey
Fri 22
BioMarin Sponsored Satellite Symposium
Q&A and closing remarks
London, UK
Fri 22
BioMarin Sponsored Satellite Symposium
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. Healthcare professionals should report adverse events in accordance with their local requirements. Adverse events should also be reported to BioMarin on + 1 415 506 6179 or [email protected].
Fri 22 17:00
Amryt Pharma Sponsored Satellite Symposium
The holistic approach to the child with lipodystrophy: The importance of timely diagnosis, intervention and education
Amazon
Chair: Ingrid Jazet (The Netherlands)
Fri 22 17:00
Amryt Pharma Sponsored Satellite Symposium
Introduction and the complex pathophysiology of leptin deficiency
The Netherlands
Fri 22 17:10
Amryt Pharma Sponsored Satellite Symposium
The early onset burden of lipodystrophy: lessons from the paediatric population
University of Ulm, Germany
Fri 22 17:35
Amryt Pharma Sponsored Satellite Symposium
Treatment approaches to the child with lipodystrophy
Cambridge, UK
Fri 22 18:00
Amryt Pharma Sponsored Satellite Symposium
Patient education initiatives in lipodystrophy: learnings from the LIPEA program
France
Fri 22 18:20
Amryt Pharma Sponsored Satellite Symposium
Conclusions and Q&A
No Session Type 4
Thu 21 17:50
Ascendis Sponsored Satellite Symposium
The future is Long-Acting Growth Hormones
Pacific
Thu 21 17:50
Ascendis Sponsored Satellite Symposium
SKYTROFA® (lonapegsomatropin): Rationale and Design
Palo Alto, USA
Thu 21 18:05
Ascendis Sponsored Satellite Symposium
LAGH Formulations: Are they all the same?
Thu 21 18:30
Ascendis Sponsored Satellite Symposium
Clinical Data and Experience with lonapegsomatropin
USA
Thu 21 19:10
Ascendis Sponsored Satellite Symposium
Panel Discussion
Fri 22 08:15
Industry Expert Forum (Novo Nordisk)
Auxological and cardiovascular outcomes of long-term GH therapy in children with Noonan syndrome
Oceania
Fri 22 08:15
Industry Expert Forum (Novo Nordisk)
Auxological and cardiovascular outcomes of long-term GH therapy in children with Noonan syndrome
Japan
Fri 22 09:00
Industry Expert Forum (Neurocrine Biosciences and Diurnal)
Overcoming obstacles on the way to a precise, effective and well-tolerated therapy for Adrenal Insufficiency and Congenital Adrenal Hyperplasia in childhood and adolescence
Oceania
Fri 22 09:00
Industry Expert Forum (Neurocrine Biosciences and Diurnal)
Welcome and Introductions
Fri 22 09:05
Industry Expert Forum (Neurocrine Biosciences and Diurnal)
Overcoming obstacles on the way to a precise, effective and well-tolerated therapy for Adrenal Insufficiency and Congenital Adrenal Hyperplasia in childhood and adolescence
Fri 22 09:25
Industry Expert Forum (Neurocrine Biosciences and Diurnal)
Questions and Answers
Fri 22 09:30
Industry Expert Forum (Neurocrine Biosciences and Diurnal)
Symposium Close
Fri 22 09:00
Industry Expert Forum (Pfizer)
How to measure for Quality of Life for pGHD in the clinic
Everest 1&2
Chair: Gary Butler (UK)
Fri 22 09:00
Industry Expert Forum (Pfizer)
Leverage unmet need, disease & treatment burden

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract